$BKTI Cashflow Statement | Understand Stock

$BKTI

$71.23 +$2.58 (3.76%) Close

$BKTI Overview Financial Statements SEC Filings Executives News Red Flags Capital Raising Ownership Insider Transactions Congressional Trades

Financial Statements

Income Statement Balance Sheet Cashflow Statement

Consolidated Statements of Cash Flows

In millions of USD; shares in millions, except per-share amounts

	FY2025 12 months to Dec 31, 2025	FY2024 12 months to Dec 31, 2024	FY2023 12 months to Dec 31, 2023	FY2022 12 months to Dec 31, 2022	FY2021 12 months to Dec 31, 2021
Operating activities
Net income
Allowance for doubtful accounts
Adjustments to reconcile net income to net cash provided by operating activities:
Deferred tax expense
Allowance for credit losses
Inventory allowance
Amortization of deferred finance and other assets
Deferred tax expense (benefit)
Share-based compensation expense -stock options
Unrealized loss on investment in securities
Depreciation and amortization
Share-based compensation expense-stock options
Share-Based Payment Arrangement, Option
Restricted Stock Units (RSUs)
Total share-based compensation expense-stock options
Share-based compensation expense-restricted stock units
Unrealized loss on investment
Loss on investment
(Gain) on sale of equipment

Changes in operating assets and liabilities:
Trade accounts receivable
Inventories
Prepaid expenses and other current assets
Capitalized product development cost
Other assets
Operating lease ROU assets and lease liabilities
Accounts payable
Accrued compensation and related taxes
Accrued warranty expense
Deferred revenue
Accrued other expenses and other current liabilities
Net cash provided by operating activities
Investing activities
Proceed from the sale of property, plant, and equipment
Purchases of property, plant and equipment
Capitalized software and systems integration costs
Proceeds for disposal of property, plant and equipment
Net cash (used in) investing activities

Financing activities
Dividends paid
Proceeds from exercise of common stock options
Proceeds from issuance of common stock warrants
Repurchase of common stock
Proceeds from credit facility and notes payable
Repayment of credit facility and notes payable
Net cash (used in) financing activities
Net change in cash and cash equivalents
Cash and cash equivalents, beginning of year
Cash and cash equivalents, end of year
Supplemental disclosure
Interest paid
Common Stock issued under restricted stock units

Non-cash financing activity
Cashless exercise of stock options and related conversion of net shares to stockholders' equity
Common stock issued under restricted stock units
Cashless exercise of stock options, warrants and related conversion of net shares to stockholders’ equity

Comments